Clinical aspects of reimbursement policies for orphan drugs in Central and Eastern European countries
S Jakubowski; Paweł Kawalec; Przemysław Holko; Iwona Kowalska‐Bobko; Maria Kamusheva; Guenka Petrova; Pero Draganić; Leoš Fuksa · 2024 · Frontiers in Pharmacology
WASTE classifies this as Negative / Null Result Report · AI classification, approximate
The study found no significant effect — useful as a negative control or null benchmark for your own design.
Abstract
Objectives: The aim of this study was to characterize the reimbursement policy for orphan drugs (ODs) in Central and Eastern European (CEE) countries in relation to the availability and impact of clinical evidence, health technology assessment (HTA) procedure, selected economic indicators, and the drug type according to indications. Materials and methods: A list of authorized medicines with orphan designation and information about active substance, Anatomical Therapeutic Chemical (ATC) classification, and therapeutic area was extracted from the web-based register of the European Medicines Agen
Abstract by S Jakubowski; Paweł Kawalec; Przemysław Holko; Iwona Kowalska‐Bobko; Maria Kamusheva; Guenka Petrova; Pero Draganić; Leoš Fuksa, Frontiers in Pharmacology (2024) — licensed CC BY 4.0.
About to run something similar?
Run an AI Precheck on your own design to catch failure modes like this one before you spend the time. Your first desk check is free.
Related failures
The Oregon Experiment — Effects of Medicaid on Clinical Outcomes
Negative / Null Result ReportMicrocredit in Theory and Practice: Using Randomized Credit Scoring for Impact Evaluation
Negative / Null Result ReportThe Cost of Carbon: Capital Market Effects of the Proposed Emission Trading Scheme (ETS)
Negative / Null Result ReportPushing on a string: US monetary policy is less powerful in recessions ∗
Negative / Null Result ReportThe Evidence on Globalisation
Negative / Null Result ReportStatistical tests for power-law cross-correlated processes
WASTE indexes this work — it does not host or republish it. Failure-type classification is automated and approximate.
Metadata source: OpenAlex · DOI 10.3389/fphar.2024.1369178